Table 3:
Adult and pediatric CMV risk categories by organ type
| Age group and organ type | No. (%) of transplants | ||||
|---|---|---|---|---|---|
| D–/R– | D+/R– | D–/R+ | D+/R+ | n | |
| Adult* | |||||
| Kidney | 451 (21.3) | 369 (17.4) | 600 (28.3) | 701 (33.1) | 2,121 |
| Liver | 179 (15.5) | 199 (17.2) | 377 (32.6) | 402 (34.7) | 1,157 |
| Heart | 120 (20.1) | 113 (18.9) | 183 (30.7) | 181 (30.3) | 597 |
| Lung | 117 (20.5) | 116 (20.3) | 135 (23.6) | 203 (35.6) | 571 |
| Total | 867 (19.5) | 797 (17.9) | 1,295 (29.1) | 1,487 (33.4) | 4,446† |
| Pediatric* | |||||
| Kidney | 30 (31.6) | 29 (30.5) | 11 (11.6) | 25 (26.3) | 95 |
| Liver | 85 (39.2) | 74 (34.1) | 31 (14.3) | 27 (12.4) | 217 |
| Heart | 42 (27.8) | 49 (32.5) | 36 (23.8) | 24 (15.9) | 151 |
| Lung | 3 (37.5) | 3 (37.5) | 1 (12.5) | 1 (12.5) | 8 |
| Total | 160 (34.0) | 155 (32.9) | 79 (16.8) | 77 (16.3) | 471† |
Notes: Seropositive and indeterminate donors and recipients aged younger than 12 mo were included in this table and were risk adjusted to be D+ or R–, respectively, to account for the potential effects of passive maternal antibody. Indeterminate donors and recipients aged older than 12 mo were risk adjusted to be D+ or R–, respectively.
* Organs were grouped as follows: kidney–pancreas with kidneys, small bowel and multivisceral with liver, and heart–lung with lung
† Exclusions due to missing serology in adults (n = 34) and pediatrics (n = 4)
CMV = Cytomegalovirus; D– = donor seronegative; R– = recipient seronegative; D+ = donor seropositive; R+ = recipient seropositive